Entering text into the input field will update the search result below

Premarket Gainers as of 9:05 am

Oct. 16, 2017 9:27 AM ETBy: Gaurav Batavia, SA News Editor8 Comments
  • TRXC +78% FDA's 510(k) clearance for its Senhance System.
  • RCON +26% on signing a three-year strategic cooperation agreement with Beijing OriginWater Purification Engineering Technology.
  • LBIX +27%.
  • RT +20% on Q2 result.
  • EXEL +16% on Cabometyx successful in late-stage liver cancer study.
  • HIIQ +14% on preliminary Q3 results.
  • VHC +13% on court document release.
  • XXII +10%.
  • OTCPK:HMNY +10%.
  • CARA +9% on successful completion of its End-of-Phase 2 Meeting with the U.S. Food and Drug Administration.
  • RWLK +8% as it begins next phase of testing in pre-clinical study.
  • NETE +8% on launching Same-Day ACH payment processing solutions.
  • AEMD +8% on collaboration with iBio (IBIO).
  • ABEO +7% on receiving grant $13.85 million for the continued advancement of lead Sanfilippo gene therapy programs.
  • PZRX +7% on analyst action.
  • ONCS +7%.
  • CLSN +7%.
  • AU +6%.
  • ETRM +6%.
  • MNKD +5%.

Recommended For You